- Home
- SHEL vs MRK Comparison
SHEL vs MRK Comparison
Compare SHEL & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHEL
- MRK
- Stock Information
- Founded
- SHEL 1907
- MRK 2000
- Country
- SHEL United Kingdom
- MRK United States
- Employees
- SHEL N/A
- MRK N/A
- Industry
- SHEL Oil & Gas Production
- MRK Biotechnology: Pharmaceutical Preparations
- Sector
- SHEL Energy
- MRK Health Care
- Exchange
- SHEL Nasdaq
- MRK Nasdaq
- Market Cap
- SHEL 212.2B
- MRK 198.5B
- IPO Year
- SHEL N/A
- MRK N/A
- Fundamental
- Price
- SHEL $74.79
- MRK $87.41
- Analyst Decision
- SHEL Buy
- MRK Buy
- Analyst Count
- SHEL 8
- MRK 14
- Target Price
- SHEL $76.44
- MRK $103.54
- AVG Volume (30 Days)
- SHEL 4.5M
- MRK 14.1M
- Earning Date
- SHEL 10-30-2025
- MRK 10-30-2025
- Dividend Yield
- SHEL 3.79%
- MRK 3.70%
- EPS Growth
- SHEL N/A
- MRK 20.41
- EPS
- SHEL 2.22
- MRK 6.49
- Revenue
- SHEL $272,011,000,000.00
- MRK $63,616,000,000.00
- Revenue This Year
- SHEL N/A
- MRK $1.84
- Revenue Next Year
- SHEL $0.49
- MRK $5.24
- P/E Ratio
- SHEL $33.79
- MRK $13.51
- Revenue Growth
- SHEL N/A
- MRK 1.82
- 52 Week Low
- SHEL $58.55
- MRK $73.31
- 52 Week High
- SHEL $75.09
- MRK $111.58
- Technical
- Relative Strength Index (RSI)
- SHEL 63.29
- MRK 60.55
- Support Level
- SHEL $71.72
- MRK $88.10
- Resistance Level
- SHEL $72.71
- MRK $91.00
- Average True Range (ATR)
- SHEL 0.81
- MRK 2.19
- MACD
- SHEL 0.29
- MRK 0.96
- Stochastic Oscillator
- SHEL 94.41
- MRK 73.62
About SHEL Shell PLC (each representing two (2))
Shell is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2024, it produced 1.5 million barrels of liquids and 7.7 billion cubic feet of natural gas per day. At year-end 2024, reserves stood at 9.6 billion barrels of oil equivalent, 48% of which consisted of liquids. Its production and reserves are in Europe, Asia, Oceania, Africa, and North and South America. The company operates refineries with a capacity of 1.6 mmb/d located in the Americas, Asia, and Europe, and sells about 12 million tons per year of chemicals. Its largest chemical plants, often integrated with its local refineries, are in Central Europe, China, Singapore, and North America.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.